PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Chlortetracycline→

Chlortetracycline PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
57-62-5
Molecular formula
C22H23ClN2O8
Molecular weight
478.9 g/mol
Drug class
Tetracycline-class antibiotic (veterinary medicinal use)
Mechanism of action
Primarily bacteriostatic. Reversibly binds the bacterial 30S ribosomal subunit at the aminoacyl-tRNA acceptor site, preventing aminoacyl-tRNA binding and inhibiting protein synthesis.
Indications / reported uses
  • Veterinary medicinal uses only in the cited authorisations; approved species and indications depend on product. Examples include treatment or control of susceptible bacterial enteritis and respiratory infections in food-producing animals, and local treatment of superficial wounds. Do not infer a human therapeutic indication.

Sources: Merck Veterinary Manual — Tetracyclines in animals · Canadian Food Inspection Agency chlortetracycline hydrochloride approved claims · UK VMD veterinary product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Chlortetracycline PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Chlortetracycline Permitted Daily Exposure (PDE) report (the Chlortetracycline PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Chlortetracycline Occupational Exposure Limit (OEL) report (the Chlortetracycline OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.